CTLA4 and cancer: Hence, increasing T cell activation and anti-tumor immune responses.151,380 By inhibiting CTLA-4, ipilimumab restores the immune system’s ability to recognize and attack cancer cells, counteracting the tumor’s immune evasion strategy of suppressing T cell activity.